Search results
Results from the WOW.Com Content Network
The French drugmaker, a market leader in anti-inflammatory drugs, has underscored its commitment to oncology drug development even after a once-promising breast cancer drug candidate flopped in 2022.
2023 was a strong year for innovative new drugs, ... The FDA is expected to make a decision about the drug in early 2024. ... CBS News. Teen charged with attempted murder in shooting of 49ers ...
In 2024, the United States suffered from an "all-time high" scarcity of over three hundred different kinds of drugs and medications in healthcare and pharmacy settings, surpassing the number of drug shortages present in 2014. Drugs and medications impacted by the shortage included asthma medications, anesthesia and analgesic medications ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
At a whopping $25 billion in sales in 2023, Keytruda was far and away Merck's top-selling drug last year. It accounted for just under 42% of the company's revenue.
A separate list for children up to 12 years of age, known as the WHO Model List of Essential Medicines for Children (EMLc), was created in 2007 and is in its 9th edition. [ 10 ][ 21 ][ 22 ][ 23 ] It was created to make sure that the needs of children were systematically considered such as availability of proper formulations. [ 24 ][ 25 ...
The two charts launched on September 19, 2020. On the Global 200, nineteen singles reached number one in 2024. Fifteen artists reached the top of the chart for the first time— Benson Boone, Beyoncé, Future, Metro Boomin, Kendrick Lamar, Hozier, Post Malone, Morgan Wallen, Tommy Richman, Eminem, Sabrina Carpenter, Jimin, Billie Eilish, Lady ...
September 17, 2024 at 7:16 PM. (Reuters) - Danish drugmaker Novo Nordisk expects its diabetes drug Ozempic will "very likely" be on the U.S. government's 2027 list of price negotiations, Bloomberg ...